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Bioassay of Metals For Carcinogenesis:
Whole Animals
by Arthur Furst*
Metals have been evaluated as potential carcinogens by administering pure elements or
compounds by alarge variety ofroutes. These include mixingthe agent in thefood, dissolvingthe
test compound in the drinking water, or administering the material by gavage. The respiratory
tract routes tested include inhalation, intratracheal instillation, the direct injection of particu-
lates into the pleural cavity, or the implantation of hooks by surgical intervention. The
parenteral routes used were intravenous injection, intraperitoneal injection, subcutaneous
implantation, as well as intrafemoral and intramuscular injection. This latter route is the most
commonly used. There are major objections to the subcutaneous implantations route, and data
generated from these experiments are difficult to interpret for the foreign body reaction may give
rise also to fibrosarcomas. This then is a nonspecific reaction.
Exotic routes tested include intrarenal, intratesticular, and intracranial injections. The
endpoints of the carcinogenic reactions are, in the main, sarcomas of certain types with
fibrosarcomas predominating. Rhabdomyosarcomas are the next most frequent cancer found,
and squamous cell carcinoma may account for less than 2% ofthe cancers reported. Much more
research is necessary to clarify the nature ofmetal carcinogenesis. Dose-response information is
almost nonexistent; the divided dose problem has not been studied adequately, and very little
information is available on interspecies reactions. More work is needed to help interpret the
mechanism of action.
Introduction
Metals as a class are often neglected in reviews
and compilations on carcinogens. Yet metals are
much more important than most ofthe academically
interesting carcinogenic agents; the use ofmetals in
manufacture is increasing, and larger segments of
the population are being exposed to metals in both
the industrial setting and in the environment.
Whenmetals arementionedinpublications, superficial
statements are often made, such as, "Recent stud-
ies have shown that nickel oxides and sulfides are
capable ofproducing muscle tumors in rodents" (1).
What is wrong with this statement is that nickel
oxide has been shown active only by the intracranial
route, and there are two sulfides ofnickel: the ore,
Ni3S2 which is active, and the more common nickel-
ous sulfide, NIS which is inactive (2).
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Perhaps, because of the extensive reviews by
Sunderman Jr. (2-5) nickel has been mentioned
most often as an example of a metal carcinogen.
The first general review of metal carcinogens
appeared in a book by Furst (6); subsequent re-
views were published by Furst and his colleagues
(7-11). The International Agency for Research on
Cancer (IARC) of the World Health Organization
has published two monographs on metals as possi-
ble risks to man (12,13) and a third appeared
recently (14).
Uniqueness of Metals as Carcinogens
Metals are different from all other carcinogens.
This may be because so little is known about the
mechanism of action of this class of agents. Unlike
the vast majority of known organic carcinogens,
this class appears not torequire activation; thus the
ion or an ion complex appears to be the ultimate
carcinogen. It is still possible that an unusual
83oxidation state of the carcinogenic element is in-
volved. Unknown as yet are three important as-
pects of action: how the element or ion penetrates
the cell membrane; how metals combine with nucleic
acids, once within the cell, and hence distort the
genetic information transmitted from cell to cell;
and how a cell recognizes the difference between a
carcinogenic ion, like Ni(II) and the noncarcinogenic
ion (Cu(II).
Generic Classification of Individual
Compounds
Should elements be classified in a generic sense,
and the term carcinogenic metal or carcinogenic ion
be used? Almost all, but not all nickel compounds
induce fibrosarcomas when injected intramuscularly
in the leg ofrats (4,15). For example, nickel sulfide
is not active (4), nor is nickel chloride (16). An
'organic compound of manganese was found to be
carcinogenic, but not the free element nor manga-
nese dioxide (17).
Itis not possible at the present time to draw final
conclusions on the basis of the available data to
determine if an element is to be classified as a
"carcinogenic element" when a single compound of
that element induces a cancer in a valid experi-
ment.
Foreign Body Carcinogenesis
What complicates this field is that rodents react
to subcutaneously or intraperitoneally implanted
solids orviscous liquids in aspecial way. In the vast
majority of the cases these rodents develop
fibrosarcomas at the site of implantation. The
physical-chemical properties ofthe implanted solid
determine the biological reaction, and a smooth
surface seems to be one major requirement (18).
Northdurft (19) first showed discs implanted
subcutaneously will produce this phenomenon. One
year later Oppenheimer et al. (20) implanted a
number of foils subcutaneously in rats and indeed
did obtain fibrosarcomas at the site ofthe implanta-
tion. This is often referred to as the Oppenheimer
Effect. Oppenheimer also induced this type of
tumor with plastic sheets (20). Subsequently
Northdurft (21) found that the tumor yield and lag
time before the appearance ofthe tumor depended
uponwhat part ofthe anatomical site wasimplanted
with the solid.
Foreign body carcinogenesis is distinct from
metal carcinogenesis. This field, using silicates as
examples, hasbeen discussed by Bryson and Bischoff
(22), and the general topic has been reviewed by
Brand (23). Any experiment which uses these two
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routes, intraperitoneal and subcutaneous, to im-
plant metals or insoluble compounds must be con-
sidered invalid.
Routes of Administration
Practically every conceivable route of adminis-
tration has been used to test pure metals or
selected compounds for their potential carcinogenic
property. A summary ofthese routes will be given
in this section. From most ofthe information found
in the literature it is very difficult or even impossi-
ble in most cases to relate the relevancy of the
results ofthese experiments to humans. Realistical-
ly, humans are exposed to metals or compounds in
the work place, as environmental pollutants in the
air, or in the drinking water. Hence, in the occupa-
tional setting the real world exposure routes are
skin contact or inhalation; in the environment,
otherhumans take in metals by inhalation orby the
oral route from the contaminated water, or from
food. With the exception of accidents, parenteral
routes of administration are not realistic for the
vast majority of humans.
Now, metal implants must be considered a route
of entry of metals into the human body, for more
and more prosthetic devices made of alloys, in
contrast to plastics, are being used less so now
than in the past. Caution must be used in the
selection of the right alloy for prostheses, such as
hip replacements; not only must the physical char-
acteristics be considered, but also the metal-tissue
interaction (24).
Many examples will be given of experiments
where different routes ofadministration have been
used; a truly exhaustive literature compilation is
beyond the scope of this review.
Oral Routes
Very few experiments have been carried out
using the oral route for chronic administration of
inorganic substances, and with very few excep-
tions, no tumors have been reported when labora-
tory animals have been given the test compounds
orally.
Gavage. One publication was found which re-
ported the administration ofa pure metal. Furst et
al. (25) gave lead powder suspended in corn oil by
stomach tube to Fischer-344 rats; no excess tumors
were found. After dosing CD hooded rats with
cadmiumchloride by stomachtube, Levy and Clack
(26) reported no tumors in two years.
Diet. This route ofadministration for metals or
their compounds has seldom been used. To date,
when compounds of metals have been mixed with
Environmental Health Perspectivesthe food and fed to experimental animals, only with
lead have tumors been reported. Among the pub-
lished experiments are: nickel sulfate given to
Wistarrats ordogs (27), bismuth oxychloride to BD
rats (28), lead arsenate or sodium arsenate to
Wistar rats (29), and two tin compounds fed to rats
(30). Boyland et al. (31) fed lead acetate at alevel of
1% in the diet to Wistar rats and found that 16 out
of 20 surviving rats developed renal carcinomas.
Van Esch et al. (32) found similar tumors also in
Wistar rats fed basic lead acetate. Van Esch and
Kroes (33) fed the same compound to Swiss mice in
the diet and again, reported that renal tumors
developed.
Water. Most of the research on treating rats
and mice orally was conducted by dissolving the
inorganic compounds in distilled water and giving
these solutions to the test animals as their drinking
water.
Perhaps the majority of the experiments in this
field were carried out by Schroeder and his col-
leagues. They dissolved a number ofcompounds at
levels to which they postulated humans were ex-
posed, and gave these solutions to their test rats or
mice. Among the compounds evaluated were: scan-
dium, chromium(VI), gallium, yttrium, rhodium,
palladium, and indium in mice (34); rhodium and
palladium exhibited a slight carcinogenic action.
Selenate but nottellurite was active in rats (35). By
this procedure none of these inorganic ions was
found to be tumorigenic in mice: chromium, lead,
cadmium, nickel, and titanium (36), nor were mercu-
ry, methylmercury, nor aluminum (37). Schroeder
summarized all of his work in a chapter entitled
"Recondite Toxicity of Trace Elements" (38).
It must be understood that Schroeder used dose
ranges of 2-5 ppm (which was his estimate of the
human exposure).
Respiratory Tract Routes
Inhalation Route. The most logical route of
administration ofpowders and dusts ofmetals is by
inhalation techniques. Results from these experi-
ments can best be related to the human experience.
Nottoo manyreports are available usingthisroute,
and-the earlier publications did not address the
difficulties and the complications of inhalation ex-
periments. A good deal is now known about which
parameters need to be measured; the distribution
ofsizes and theparticle sizerange are ofparamount
importance (39). These data are needed to make
decisions regarding how much and where in the
respiratory tract the particles are lodged. Informa-
tion on the deposition ofparticles in therespiratory
tract in both the human and experimental animals
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is well documented and is covered in a recent
review (40).
Metallic nickel powder (no data were given on
particle size) was tested by Hueper (41), who
exposed both rats and guineapigs. Both species did
develop lungtumors. This is an unusual finding, for
guineapigs are amongthe most resistant ofspecies
to the induction ofcancerby chemicals. Saknyn and
Blokhin (42) reported that 1/26 rats exposed to dust
containingnickel, aproduct used forthe production
of nickel-black, developed a squamous cell carci-
noma without keratinization. Wehner (43), on the
other hand, exposed hamsters over their life span
to nickel oxide and found no carcinogenic response.
An inhalation experiment with nickel sulfide* re-
sulted in the exposed Fischer-344 rats developing
various types of lung tumors (44).
No tumors were found when rats were exposed
to ammonium bichromate (45). Beryl did induce
some lung tumors in rats, but not in monkeys;
squamous cell carcinoma was not found (46). Sand-
ers et al. (47) exposed rats, nose only, to high-fired
oxides of beryllium and found only 1/184 rats
developed a lung tumor in the two-year exposure
period.
ImplantationandIntrathoracic. Inanattempt
to evaluate calcium chromate as a lung carcinogen,
Laskin et al. (48) surgically implanted small metal-
lic hooks in the lungs of rats; attached to these
hooks were threads soaked in calcium chromate.
Furst et al. (49) induced mesotheliomas in Fisher
344 rats by the intrathoracic injection of a suspen-
sion of powdered cadmium. Bischoff and Bryson
(50) did similar studies injecting tin needles into
mice lungs; no tumors were found. All of these
techniques are traumatic.
IntratrachealMethods. Certainlyinhalationmim-
ics the human experience best when exposures to
powders, dusts, and aerosols are to be considered.
Practically, it may not be possible to do exposures
by the inhalation route for a number of reasons,
although aerosols have been recently tested rou-
tinely (51). Ifthe metal can not be suspended in air,
thesecondchoicewillbetheintratrachealinstillation
technique. This procedure becomes the first choice,
if it is necessary to deposit on the lung surface a
quantitative amount of the compound.
The most extensive use of this technique has
been with chromates instilled into various strains of
rats. An IARC monograph recently published (14)
reviews these studies and evaluates the results.
*The authors call theircompound nickel sulfide. Although this
term is used in the trade, the actual compound used was
apparently the nickel subsulfide. There is some confusion in the
abstract literature concerning the chemical tested.
85Hamsters have been the animal of choice when
hydrocarbonshavebeentestedfortheircarcinogenic
properties relative to the respiratory tract. During
the course ofthe hydrocarbon studies, ferric oxide
was used as a carrier; this compound had to be
tested as a control without the adsorbed benzo(a)
pyrene (52). None of the control animals treated
withthe metallic compound, ferric oxide, developed
lung cancers.
Ho and Furst (53) adopted this intratracheal
instillation technique for use on mice, and demon-
strated that the ferric oxide is widely distributed in
the lungs of the instilled mice; the compound was
not completely cleared even after two years. No
neoplasms were found in the mouse lungs treated
with ferric oxide in life-time studies.
Kasprzak et al. (54) instilled nickel subsulfide
alone into rat lungs and after a period of time no
tumors were reported; the combination, however,
of this subsulfide and benzo(a)pyrene did produce
lung cancer. It must be recognized that the nickel
compound may have acted only as a carrier.
Tracheal Implants. Among the newer tech-
niques developed to test the carcinogenicity of
compounds is the use of tracheal grafts. The
trachea of a test animal is carefully removed after
sacrificing the animal and so cut that discrete rings
are formed. A suspension of the metal compound
under test is poured into the ring and permitted to
harden; at that point the rings are transplanted
subcutaneously into isogenic recipients; about two
to six tracheas per rat are implanted. After a
specific time the tracheas of the rats are removed
and examined.
Using this technique, Lane and Mass (55) tested
chromium carbonyl and found that 1/6 and 1/3
tracheas had squamous cell carcinomas; five of the
Wistar Lewis rats with 2-5 tracheas each did not
develop tumors. The experiments lasted 12-14
months. Tsutomu and Nettesheim (56) implanted
two tracheal rings per female Fischer 344 rat, each
graft containing 1 or 3 mg ofnickel subsulfide. The
experiments were carried out up to 20 months.
Only 10% of the grafts were found with tumors;
67% of these were fibrosarcomas, and 1.3% were
carcinomas.
Topical Application
Since humans are exposed to metal compounds
by skin contact, especially in the work place, it is
logical to study some suspect compounds for their
activity by skin painting. Practically no publica-
tions are available where this route has been
adequately tested using metal compounds. Both
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Khachatrikn4557))nd Kovalenko q{al. (45eported
skin paintihm ith chromium co ds; neither
reported that tumors developed.
Parenteral Routes
The relevancy ofdata obtained byinjectingmetal
compounds intotest animals as appliedto humans is
questionable. Yet for convenience, and to answer
academic questions, these routes arethe most often
used. It is importantto knowthatthe subcutaneous
implantation route gives rise to site-implanted
fibrosarcomas which may even metastasize to the
lungs. However, because of the nonspecific aspect
ofthisroute, noextrapolationto human should ever
be attempted when the only test route is subcuta-
neous for solids or viscous liquids.
In our laboratories we are finding another
nonspecific pathological reaction. A few metals
when implanted intramuscularly seem to induce
osteosarcomas which also metastasize to the lungs.
It does appear that this phenomenon should be
considered an artifact of the experimental tech-
nique, rather than a true carcinogenic reaction to
be related to the metal implant.
Intravenous Injection. Beryllium compounds
have been given to rabbits by the intravenous
route, and osteogenic sarcomas have developed
(58); this route has been used by Schmahl and
Steinhoff (59) to inject colloidal silver weekly into
rats; a few tumors were found. Colloidal gold failed
to induce tumors. Sunderman's group (60) gave six
intravenous injections of nickel carbonyl (0.9 mg
Ni/100 g) to Sprague-Dawley rats and found a
variety oftumors; significantly, no squamous carci-
noma of the lungs was reported.
Intraperitoneal Injection. The intraperitoneal
injection of solids, dusts, or sparingly soluble met-
als, especially solids with smooth surfaces, in all
probability will give rise to the nonspecific foreign
body response, and in almost all cases will lead to
the formation of fibrosarcomas at the site of injec-
tion. The reaction of mercury droplets injected
intraperitoneally may be just this smooth surface
effect (61). Soluble compounds which give rise to
fibrosarcomas at the site may also not be true metal
carcinogens.
Perhaps a different interpretation is needed
when soluble compounds induce tumors at a site
distantfromthepointofapplication. Goldthioglucose,
when injected into female C57B1 mice produced
obesity, and later the animals developed reticulo-
sarcomas; there was no change in the expected
spontaneous incidence of tumors (62).
Shimkin's group (63) uses the intraperitoneal
Environmental Health Perspectivesroute to inject solutions ofcompounds to determine
if they modify the incidence of the spontaneous
pulmonary adenomas in Strain A mice. Before this
method can be adopted as a screening procedure it
must be validated by the testing of many more
compounds, and the results compared with infor-
mation obtained by other routes.
Subcutaneous Implant. The one route which
should not be used to evaluate metals is subcutane-
ousimplantation. Since the findings ofOppenheimer
(20)andofNorthdurft(19)thatalmostanyimplanted
solid may induce a fibrosarcoma at the site, it is
difficult to interpret the carcinogenicity ofvitallium
reported by Maltoni (64). Before conclusions can be
drawn, this compound must be checked by another
route, such as intramuscular. Doubt must also be
cast on the report that rare earths such as gadolin-
ium and ytterbium are carcinogenic because they
induced fibrosarcomas following the subcutaneous
implant of pellets into mice (65).
Similartotheremarksmadeunderintraperitoneal
routes, the appearance of tumors at the site after
the subcutaneous injection of some soluble com-
pounds may not be an indication of a true metal
carcinogen. Cobalt chloride (66) and cadmium chlo-
ride (67) did induce local fibrosarcomas. In neither
study did the authors determine if the compound
precipitated atthe site and thus became animplanted
solid.
IntramuscularInjection. The most commonly
used route to evaluate metals and their insoluble
compounds as potential carcinogens is the intra-
muscular route. Usually powders are suspended in
inert vehicles and injected deep into the thigh
muscle of the rodent. Following the investigations
of Gilman and Ruckerbauer (68), who found nickel
subsulfide an active carcinogen using the intramus-
cular route, many others have used this procedure
to test other metals and their compounds. Nickel
subsulfide has beenthoroughly testedbySunderman,
and the information is summarized in his elegant
review (4).
Unlike either the subcutaneous or intraperitoneal
routes, the intramuscular route can be used to
differentiate between active and inactive compounds,
at least under the conditions ofthese experiments.
In the original experiment where nickel subsulfide
was found carcinogenic (68), nickel sulfate was
inactive, as were ferrous sulfide and copper sulfide.
Furst and Schlauder (69) were able to distinguish
between the carcinogenic activity ofcadmium pow-
der and the nonactive silver and gold powders.
Many examples can be given, and comparisons of
different compounds of the same element can be
made; for instance both the oxide and the sulfide of
cadmium induced tumors (70). Until contrary in-
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formation becomes available, the intramuscular
route would be the route of choice for the evalua-
tion of metals and their sparingly soluble com-
pounds; the experimental conditions to be met are
that the fine powders be suspended in an inert
vehicle, and that no discs be tested. However, it
must be recognized that the relevance ofthis route
to the human situation cannot be evaluated at the
present time.
IntrafemoralInjection. In his pioneeringwork
on metal carcinogenesis, Hueper (71) suspended
nickel powder in a fatty vehicle and injected the
mixture into a previously drilled hole in the femur.
Fibrosarcomas resulted from this treatment. He
was one of the very few to use this route. More
recently, Mazabraud (72) injected zinc beryllium
silicate into the tibial or femoral epiphysis and
produced osteosarcomas in 70% of his treated
rabbits. Since otherroutes can give similarresults,
this route is not recommended.
Miscellaneous Routes
Metals and their compounds have also been
evaluated as potential carcinogenic agents by at
least three unusual routes of administration. Al-
though these routes were exotic, not all compounds
tested by theseroutes ofadministration were found
to induce tumors.
Intratesticular Injection. Perhaps the very
first indication that an inorganic compound could
induce a tumor in an animal was the work of
Michalowsky (73), who in 1926 injected zinc chlo-
ride in the testes of roosters and later found
teratomas. This experiment was repeated by Falin
and Gromtseve (74) with zinc sulfate. Bythisroute,
coppersulfate was also found active (75). Tumors of
the testes can also be induced in rats with zinc
chloride (76) and by the implantation of nickel
subsulfide (77).
Intrarenal Injection. Nickel subsultide was
injected intrarenally by a surgical technique into
Sprague-Dawleyfemale rats (78). Between8and 12
months, 40% of the test animals developed renal
carcinomas which tended to evolve toward an
anaplastic, spindle-cell variant. This compound was
the only one which did induce the tumor; negative
results were obtained with pure metal powders of
nickel, cobalt, chromium, cadmium, lead, and gold.
Cobalt sulfide, also tested, failed to induce tumors.
Intracranial Implantation. One of the very
few routes by which nickel oxide induced cancer
was by intracranial implantation (79). After a
period of time, both sarcomas and meningiomas
were found at the site of implantation.
87Endpoints Found
A select group of pure metals, and some oftheir
inorganic or organic compounds, are among the
most potent of the chemical carcinogens. These
agents have definitely induced malignant tumors in
experimental animals; they fulfill the most strin-
gent criteria which would determine whether a
compound can be considered a true carcinogen (7).
The time of appearance and the percentage of
animals with tumors depends on the nature of the
individual compound. Not enough dose relation-
ships have been made to draw conclusions on this
aspect of carcinogenesis.
Induced Malignancies
The vast majority of the tumors reported to be
induced bymetals andtheircompounds areclassified
as sarcomas. Fibrosarcomas predominate; these
are invariably found at the site ofimplantation. The
degrees of malignancy also vary. Both well and
poorly differentiated fibrosarcomas have been de-
scribed. Some years ago it was suggested that
nickel was specific for the induction of rhabdo-
myosarcomas only; now it is recognized that com-
pounds of nickel can induce leiomyosarcomas,
fibromyosarcomas, fibromyxosarcomas, as well as
sarcomas of uncertain types.
As noted, when beryllium compounds are
administered intravenously, osteosarcomas appear.
This author now believes that these tumors may be
an artifact when solid inorganic compounds are
injected intramuscularly too near a bone.
Very few carcinomas have been induced when
metals and their compounds have been evaluated
for their potential carcinogenicity. This tumor type
was found in the intrarenal injection experiments,
and a few were found in the treated trachealgrafts.
Nickel carbonyl gas delivered to rats by the inhala-
tion route was reported to induce squamous cell
carcinoma of the lungs; this compound given
intravenously, however, did not induce this cancer
in the treated rats.
Nonmalignant Lesions
Injected metal powders have produced a variety
of pathological conditions in the treated animals.
The injected sites have at times become necrotic,
leading to avariety ofinfections. Adverse reactions
have been oftenmistaken forgrowths. Hemangiomas
have also been seen.
Once in a while, a specific reaction is noted, such
as the atrophy ofthe testes inthe male rats treated
with cadmium powder. An entire review is neces-
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sary for the description ofthe nonmalignant lesions
found in the metal-treated animals.
Public Health Implications
Metals as such, or in alloys or catalysts, or as
components in the electronic industries, and finally
as components ininorganic and organic compounds,
are being introduced into our civilization at a rapid
rate. The general population is being exposed to
greater quantities of these chemicals; the greatest
health problem exists in the workerwho is involved
in the manufacture ofmetals or in the use ofthese
materials.
Cancer does seem to appear more frequently
among groups of workers who are exposed as
copperminers, copper smelters (80) nickelrefiners,
orthose whoworkwith chromates (81). Sunderman
(2) and Furst and Radding (14) have summarized
the evidence forthe nickel workers. It appears that
the rates ofcancer in this latter group are decreas-
ing. Chromates have been implicated for a very
long time as a metal carcinogen. The 1980 IARC
review (14) has an overview ofthe entire chromate
picture.
In addition to industrial exposure humans can be
incontact with metalsfrom the drinkingwater, and
the polluted air. Some authors have attempted to
correlate the concentration of carcinogenic trace
metals in water supplies with cancer mortality of
selected populations (82). (It is of interest that
government agencies seem to give more attention
to the organic compounds in drinking water than to
its metal content.)
Gaps in Knowledge
Metal carcinogenesis, perhaps the least studied
ofanymajorclass ofactive agents, requires further
exploration.
Obviously the mechanism ofaction is not known,
and the nature ofthe metal-nucleic acid interaction
must be determined. Even before this important
work, there must come some knowledge of the
interaction of metal ions with proteins and small
peptides of biological fluids. These studies may
shed some light on how the ion crosses the cell
membrane and actually gets into the cell to inter-
act, if it does, with the intracellular DNA. Un-
known also is how the nucleic acids are changed
after the carcinogenic metal interacts with the
normalnucleic acid. Finally, there is no information
whatsoeverto tellhow acell differentiates between
acarcinogenic ion or compound and an inactive one.
Thus there is insufficient knowledge for predicting
which metals will be carcinogenic.
Environmental Health PerspectivesRecommended Research
In ordertounderstandmore aboutmetalcarcino-
genesis, more research should be conducted both in
vivo and in vitro along these lines.
1. DOSE-RESPONSE. Too few studies have been
conducted torelate the effect ofthe dose levelgiven
to animals and the tumoryield. The lagtime before
tumors appear must also be further investigated.
(Atleast bythe intramuscular route itis possible to
palpate early tumors at the site ofinjection without
sacrificing the animals. By use of calipers it is
possible to get rate of increase of tumor size with
time also.) To date most ofthe work has been done
with a single high dose being administered to the
test animals.
2. DIVIDED DOSE. Information is needed on the
tumor yield when an animal is treated with a
specific dose. That dose may be given as a single
injection, or given over a period oftime in smaller
increments. These studies should include the effect
of the time interval on the tumor yield; if a
sparingly soluble compound or a pure metal is
administered, the previous dose will not be ex-
creted before the next injection is given.
3. Low DOSE. It would be most useful to obtain
data on the effect of giving animals a dose of a
compound which would result in a tumor yield of
90+%, and then repeat these experiments with
doses which are decreased by logarithmic units.
4. ROUTES COMPARED. It will be of interest to
see what information is obtained ifthe same labora-
tory uses atleasttworoutes to administerthe same
compound at equal dose levels. How does intramus-
cularcompare withthe oralroute? Muchmore work
must be done to evaluate the oral route. Here also,
dose response studies must be made. With the
exception ofthe chromates, the intratracheal route
has been neglected. This route can give quite a bit
of information about lung reactions, as well as the
potential carcinogenicity of the compounds.
5. COMPOUNDS COMPARED. It is still unknown
what conclusions can be drawn relative to a pure
element if one of its compounds is found active.
6. SPECIES COMPARED. To extrapolate informa-
tion derived from animal studies to humans, much
more data must be obtained on species to species
variation. It is essential to know ifthe carcinogenic
response of a rat or mouse is not the result of
species specificity. Reviews arejust now appearing
on this subject (83).
7. RATES OF EXCRETION. How rapidly are the
metals excreted, and by what routes are they
eliminated when pure metals are administered by
gastrointestinal or by the parenteral routes?
8. RATES OF DISSOLUTION. How fast are com-
pounds dissolved in the animal when given by the
different routes? Whatis the chemical nature ofthe
transported ion?
9. ARTIFACTS. What artifacts are related to the
experimental techniques. Are there similar effects
to the "Oppenheimer Effect" yet to be observed?
(As mentioned, the author believes the appearance
of osteosarcomas may be an artifact.)
10. MORE TESTING. What other industrial com-
pounds are potential carcinogens?
11. In vivo MECHANISMS. Can in vivo studies
helpdetermine themechanismofaction ofthis class
ofcompounds, or must the work be done only in in
vitro systems? Does a metal combination with a
DNA in the test tube describe what goes on in the
cell of a live treated animal?
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